CF
IDXX icon

Copperwynd Financial’s Idexx Laboratories IDXX Stock Holding History

Copperwynd Financial’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-34,038
Closed -$8.5M – 97
2018
Q3 		$8.5M Buy
34,038
+31,824
+1,437% +$7.73M 5.15% 6
2018
Q2 		$483K Buy
+2,214
New +$456K 0.34% 39

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Copperwynd Financial's IDXX Position: Q4 2018 in Review

Copperwynd Financial sold out of Idexx Laboratories (IDXX) in Q4 2018, closing a stake of 34,038 shares — an estimated $8.5M sold.

Copperwynd Financial first reported a position in IDXX in Q2 2018 and held it in 2 quarters. The position peaked at $8.5M in Q3 2018. 670 funds tracked by Wall St. Rank hold IDXX as of Q4 2018.

  • Copperwynd Financial reported no remaining Idexx Laboratories position as of Q4 2018 after selling out during the quarter.
  • Copperwynd Financial sold 34,038 Idexx Laboratories shares in Q4 2018, an estimated $8.5M.
  • Copperwynd Financial first reported a position in Idexx Laboratories in Q2 2018 and held it in 2 quarters.
  • Copperwynd Financial's Idexx Laboratories position peaked at $8.5M in Q3 2018.
  • 670 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2018.

Based on Copperwynd Financial's 13F filing for Q4 2018, filed 8 Feb 2019.